Liang, Zaolan http://orcid.org/0009-0008-1626-4955
Lin, Xia
Sun, Lihong
Edwards, Kimberly M. http://orcid.org/0000-0003-0944-3118
Song, Wenjun http://orcid.org/0000-0002-0165-7894
Sun, Hailiang
Xie, Yanmin
Lin, Fangmei
Ling, Shiman
Liang, Tingting
Xiao, Biying
Wang, Jiaqi
Li, Min
Leung, Chin-Yu
Zhu, Huachen http://orcid.org/0000-0003-2711-0501
Bhandari, Nisha http://orcid.org/0009-0009-6881-6552
Varadarajan, Raghavan http://orcid.org/0000-0002-0823-7577
Levine, Min Z. http://orcid.org/0000-0002-3197-1649
Peiris, Malik http://orcid.org/0000-0001-8217-5995
Webster, Robert
Dhanasekaran, Vijaykrishna http://orcid.org/0000-0003-3293-6279
Leung, Nancy H. L.
Cowling, Benjamin J. http://orcid.org/0000-0002-6297-7154
Webby, Richard J. http://orcid.org/0000-0002-4397-7132
Ducatez, Mariette
Zanin, Mark
Wong, Sook-San http://orcid.org/0000-0002-1290-191X
Article History
Received: 22 August 2023
Accepted: 24 June 2024
First Online: 3 July 2024
Competing interests
: B.J.C. has consulted for AstraZeneca, Fosun Pharma, GlaxoSmithKline, Haleon, Moderna, Novavax, Pfizer, Roche, and Sanofi Pasteur. S.S.W. has received speakers honorarium from Sanofi Pasteur. All other authors declare no competing interests.